Metabolomics & Pharmacology

Pharmacogenomics has some impact in clinical practice, through its use to select patient subgroups who will enjoy efficacy without side effects when treated with certain drugs. However, pharmacogenomics, has had less impact than initially predicted. One reason for this is that many diseases, and the way in which the patients respond to drug treatments, have both genetic and environmental elements. Pure genomics is almost blind to the environmental elements. A new methodology has emerged, termed pharmacometabolomics that is concerned with the prediction of drug effects through the analysis of pre-dose, biofluid metabolite profiles, which reflect both genetic and environmental influences on human physiology.

 

  • Implications of Clinical Pharmacology
  • Pharmaceutical research & Metabolomics in the New born

Related Conference of Metabolomics & Pharmacology

April 03-04, 2023

International Conference on Aging and Gerontology

Rome, Aland Islands
May 03-04, 2023

16th World Congress on Stem Cell Research

Paris, France
May 03-04, 2023

Global Conference on Cell and Gene Therapy

Paris, France
June 09-10, 2023

10th World Congress on Epigenetics and Chromosome

Valencia, Spain
June 28-29, 2023

27th Global Congress on Biotechnology

Toronto, Canada
September 25-26, 2023

19th Global Summit on Stem Cell & Regenerative Medicine

Zurich, Switzerland
October 19-20, 2023

5th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada
December 07-08, 2023

17th International Conference on Genomics & Pharmacogenomics

San Francisco, USA

Metabolomics & Pharmacology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in